CORPORATE RESPONSIBILITY - Every voice matters
MAKING A DIFFERENCE WHERE IT MATTERS MOST
At Essential Pharma, corporate responsibility is at the core of everything we do, rooted in a powerful belief that every patient matters. As a global pharmaceutical company, we embrace our responsibility not just to our patients in niche, underserved, or rare disease populations, but also to society, the environment, and the broader healthcare ecosystem.
OUR ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITMENT
OUR COMMITMENT
We are committed to standing up for patients who might otherwise be overlooked. We do this by investing in and commercialising medicines that are difficult to manufacture or otherwise at risk of discontinuation – and by working to create new medicines where there is high unmet need. We don’t walk away from these challenges; we embrace them, driven by a strong sense of responsibility to support patients who have few options.
Our team takes on what others often won’t, because we believe access to critical medicines should not depend on patient population size. These commitments enable us to deliver high-quality products and services that can transform the lives of patients around the world.
We also recognise our broader responsibilities to society, the environment, and the communities in which we operate. That’s why we’ve embedded a robust ESG framework into our operations, with a clear commitment to the areas that matter most to our patients, our partners and our planet.
Colin Brown
Chief Operating Officer, Essential Pharma
“We are immensely proud of the continued efforts and dedication of our team to ESG principles, which are woven into every facet of Essential Pharma’s business. Our ESG infrastructure is designed to support our company’s sustainable growth while ensuring that we meet our commercial objectives in a responsible manner.
The significant improvements across all four categories – Environmental, Social, Governance, and Overall – compared to last year’s scores are a testament to our dedication to sustainability and responsible business practices. Notably, our performance continues to exceed the improving sector benchmark, reflecting our industry leadership in ESG initiatives. An ‘Excellent’ overall rating is now within reach and, with our proactive approach to continuing improvement, I am confident that we will achieve this milestone by 2025.
The contribution of our MERIT Team (Making the Environment Rewarding by Inspiring Togetherness) has been instrumental in driving these outcomes, and their dedication exemplifies our collective commitment to making a meaningful and lasting impact on society whilst minimising effects on the environment. It is rewarding to see how far we have come in integrating sustainability, ethical practices, and social responsibility into every aspect of our rapidly growing, dynamic business. Our dedication to ESG not only shapes our identity but fuels our mission to maintain continuity of supply of Essential medicines to patients, ensuring a healthier, more sustainable future for all.”
